Investigating the Association Between P2Y12 Receptor, SV2A, and Tau Expression in Postmortem AD and Control Brains Using <i>In Vitro</i> Autoradiography
This study demonstrates that SV2A levels decrease while tau accumulations increase in AD brains with [<sup>3</sup>H]UCB-J and [<sup>18</sup>F]MK-6420 respectively, and our data is consistent with in vivo human PET imaging studies of SV2A and tau. We also showed that P2Y12R is decreased in AD brains with [<sup>3</sup>H]PSB-0413. Positive correlation between regional binding of the three tracers was shown in AD patients.
Authors
- Chao Zheng
- Neil Vasdev (ORCID: https://orcid.org/0000-0002-2087-5125)
- Ruiqing Ni
- Hannah Le
- Roger Raymond
Institutions
- Centre for Addiction and Mental Health (CA)
- University of Toronto (CA)
- University of Zurich (CH)
- ETH Zurich (CH)
- Institute for Biomedical Engineering (CH)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_102328
- Citations
- 1
- Primary Topic
- Adenosine and Purinergic Signaling
- Type
- article
- Field-Weighted Citation Impact
- 1.12